Jamie N. Hadac, Ph.D. - Publications

Affiliations: 
2014 Cancer Biology University of Wisconsin, Madison, Madison, WI 
Area:
Genetics, Molecular Biology, Oncology, Public Health

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Hadac JN, Miller DD, Grimes IC, Clipson L, Newton MA, Schelman WR, Halberg RB. Heterochromatin Protein 1 Binding Protein 3 Expression as a Candidate Marker of Intrinsic 5-Fluorouracil Resistance. Anticancer Research. 36: 845-52. PMID 26976970  0.589
2015 Hadac JN, Leystra AA, Paul Olson TJ, Maher ME, Payne SN, Yueh AE, Schwartz AR, Albrecht DM, Clipson L, Pasch CA, Matkowskyj KA, Halberg RB, Deming DA. Colon Tumors with the Simultaneous Induction of Driver Mutations in APC, KRAS, and PIK3CA Still Progress through the Adenoma-to-carcinoma Sequence. Cancer Prevention Research (Philadelphia, Pa.). PMID 26276752 DOI: 10.1158/1940-6207.Capr-15-0003  0.705
2014 Paul Olson TJ, Hadac JN, Sievers CK, Leystra AA, Deming DA, Zahm CD, Albrecht DM, Nomura A, Nettekoven LA, Plesh LK, Clipson L, Sullivan R, Newton MA, Schelman WR, Halberg RB. Dynamic tumor growth patterns in a novel murine model of colorectal cancer. Cancer Prevention Research (Philadelphia, Pa.). 7: 105-13. PMID 24196829 DOI: 10.1158/1940-6207.Capr-13-0163  0.652
2014 Hadac JN, Olson TJP, Leystra AA, Albrecht DM, Clipson L, Sullivan R, Newton MA, Halberg RB, Schelman WR. Abstract 2356: Characterization of molecular signatures predicting response to 5-FU based chemotherapy in mouse models of colorectal cancer Cancer Research. 74: 2356-2356. DOI: 10.1158/1538-7445.Am2014-2356  0.771
2013 Hadac JN, Olson TJP, Newton MA, Kennedy GD, Schelman WR, Halberg RB. Abstract 2726: Tumor progression and treatment response characterization in a novel mouse model of colon cancer. Cancer Research. 73: 2726-2726. DOI: 10.1158/1538-7445.Am2013-2726  0.765
2012 Leystra AA, Deming DA, Zahm CD, Farhoud M, Olson TJ, Hadac JN, Nettekoven LA, Albrecht DM, Clipson L, Sullivan R, Washington MK, Torrealba JR, Weichert JP, Halberg RB. Mice expressing activated PI3K rapidly develop advanced colon cancer. Cancer Research. 72: 2931-6. PMID 22525701 DOI: 10.1158/0008-5472.Can-11-4097  0.638
Show low-probability matches.